Literature DB >> 20708911

HER2 testing, adjuvant trastuzumab use and results. Our experience in South Wales.

R Webster, N Palaniappan, J Abraham, G Bertelli, B Jasani, P Barrett-Lee.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20708911     DOI： 10.1016/j.clon.2010.07.003

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN： 0936-6555            Impact factor:   4.126


× No keyword cloud information.
  3 in total

1.  HER2 evaluation and its impact on breast cancer treatment decisions.

Authors:  K A B Goddard; S Weinmann; K Richert-Boe; C Chen; J Bulkley; C Wax
Journal:  Public Health Genomics       Date:  2011-05-03       Impact factor: 2.000

2.  Exploring the use and impact of adjuvant trastuzumab for HER2-positive breast cancer patients in a large UK cancer network. Do the results of international clinical trials translate into a similar benefit for patients in South East Wales?

Authors:  R M Webster; J Abraham; N Palaniappan; A Caley; B Jasani; P Barrett-Lee
Journal:  Br J Cancer       Date:  2011-11-22       Impact factor: 7.640

3.  Closing the personalized medicine information gap: HER2 test documentation practice.

Authors:  Ilia L Ferrusi; Craig C Earle; Maureen Trudeau; Natasha B Leighl; Eleanor Pullenayegum; Hoa Khong; Jeffrey S Hoch; Deborah A Marshall
Journal:  Am J Manag Care       Date:  2013-01       Impact factor: 2.229
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.